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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To explore the effectiveness of interventions delivered with the aim of involving older patients with multimorbidity in decision-making
about their health care during primary care consultations.
B A C K G R O U N D
Description of the condition
Life expectancy is predicted to continue to rise globally (Oeppen
2002), and the prevalence of long-term conditions also increases
with age (Melzer 2015). The presence of more than one long-
term health problem is termed multimorbidity. Quality of care
for older patients with multimorbidity may be worsening when
compared to the management of patients with long-term condi-
tions in general (Higashi 2007; Steel 2014). The consequences of
multimorbidity include functional decline with poor quality of
life, high healthcare utilisation and costs, reduced life expectancy,
and a negative impact on the health of carers (Academy ofMedical
Sciences 2018; Marengoni 2011).
Our previous work identified that older patients value being in-
volved in decision-making about their health care (Butterworth
2014).However, they are less frequently involved in decision-mak-
ingwhen comparedwith younger patients (van denBrink-Muinen
2006). There is some evidence of associated health inequalities,
including discrepancies in rates of referral and requests for inves-
tigation (Drennan 2007; McBride 2010; Tate 2010).
The importance of involving older patients with multimorbid-
ity in decision-making about their care when seeking to identify
unmet healthcare needs, has been acknowledged (Couët 2015;
Department of Health and Social Care (UK) 2001; Homa 2015;
Iliffe 2004; Noël 2007). Older patients need support in priori-
tising and rationalising treatment options to maximise quality of
life and day-to-day function (Kiesler 2006; Peters 1994). Recent
research suggests that supporting older patients with multimor-
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bidity in communicating their needs and concerns to healthcare
providers could reduce risks to patient safety (Hays 2017).
‘Old age’ refers to somebody nearing the end of the natural human
life cycle. Whilst the widely accepted definition of an older person
in westernised countries encompasses individuals aged 65 years
and above, with the rise in life expectancy, this age category is be-
coming increasingly vast (Dong 2016; Oeppen 2002). Therefore,
theremay be differing healthcare requirements across the widening
older age group that must be considered by future research, and in
particular by intervention studies designed to support the needs of
this patient group. Many currently available interventions appear
outdated in their assessments of this population with regard to
their wish for involvement in decision-making about their health
care.
Description of the intervention
This Cochrane Review will assess the effects of interventions for
older patients withmultimorbidity with the aim of involving them
in decision-making about their health care during primary care
consultations. We searched the literature for systematic reviews of
similar interventions to inform the description of interventions
to be included in this review (Kinnersley 2008; Légaré 2018;
Smith 2016; Wetzels 2007). Our description of the components
of patient involvement in decision-making is also influenced by
the components of patient-centred care as suggested by Wensing
2003.
Interventions may be delivered either prior or during a single con-
sultation, or they may span multiple consultations. Studies may
encompass one of three types of intervention centred around a
consultation with a primary healthcare practitioner or they may
include elements of all three:
• patient-focused e.g. written or online decision-support
tools such as ‘option grids’, that can either be completed with a
practitioner during a consultation or completed by the patient
outside of, and prior, to the consultation;
• practitioner-focused e.g. communication skills training for
use during a consultation;
• relate to organisational change e.g. increased length of the
consultation.
Interventions may be delivered, as well as received, by primary
care practitioners, or they may be delivered by external clinicians/
researchers, or by administration staff. Theymay also be facilitated
by a patient’s carer (a family member or paid helper who regularly
looks after the patient), who may or may not be present during a
consultation.
Wewill consider all interventions designed to facilitate the involve-
ment of patients with multimorbidity in decision-making about
their health care during primary care consultations.
How the intervention might work
Within the patient-practitioner consultation, patient involvement
in decision-making refers to activities carried out by:
• a practitioner, seeking to facilitate a patient’s active
engagement in decision-making within the consultation
(including the use of ‘shared decision-making’ related
communication skills, and/or encouraging patient autonomy
and empowering self-management, and/or changing the way that
information is delivered to meet patient preferences); and
• patients. to increase their own involvement in decision-
making during the consultation (including expressing a
preference for involvement, the use of written decision-making
support tools, and taking ownership of patient-held records).
In addition, changes can be made to the organisation of care, so
that healthcare services more comprehensively address patients’
needs and preferences, to enable patient involvement in decision-
making about their health care. Therefore a third approach to pa-
tient involvement in decision-making is directed towards improv-
ing the quality of healthcare delivery within the consultation, and
might include longer consultations (to allow time for patient in-
volvement in decision-making to take place, for example), or sys-
tem improvements to enable continuity of care with an individual
practitioner (Wensing 2003).
Shared decision-making has been defined as “an approach where
clinicians and patients share the best available evidence when
faced with the task of making decisions, and where patients are
supported to consider options, to achieve informed preferences”
(Elwyn 2010). Shared decision-making during healthcare con-
sultations has previously been identified as a priority feature of
high quality patient-centred care (WHO 1994). Delivering such
care is associated with improved outcomes for patients, doctors,
and healthcare teams. These include patient adherence with treat-
ment advice, satisfaction with health care, and trust in the doctor
(Croker 2013; Flocke 2013; Loh 2007; Ommen 2011).
The primary care practitioner’s role in shared decision-making in-
volves seeking the patient’s implicit or explicit involvement in the
decision-making process; exploring the patient’s ideas, fears, and
expectations about the problem and possible treatments; provid-
ing a balanced view in the discussion of healthcare options; iden-
tifying the patient’s preferred data format to provide tailor-made
healthcare information; checking the patient’s understanding of
the information and their reactions to it; asking for the patient’s
decision-making role preference; making, discussing, or deferring
decisions with the patient; and arranging for appropriate follow-
up (Elwyn 2000).
Whilst many studies have reported patients’ positive views of the
processes of involvement in decision-making about their health
care, some have suggested that older patients may not value feel-
ing involved in this way (Levinson 2005). Our previous work
used qualitative methods to examine these apparent conflicts
(Butterworth 2014). We found that, in general, older patients do
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value feeling involved in the decision-making process, but it is im-
portant to recognise that patient perceptions vary regarding what
it means to be involved (Berkelmans 2010; Kiesler 2006). For ex-
ample, some participants did not report valuing every element of
a shared decision-making approach, identified as being of impor-
tance in the literature (Elwyn 2000). We therefore plan to con-
sider studies evaluating all interventions designed to facilitate the
involvement of patients with multimorbidity in decision-making
about their care, in order to understand the effects of these in-
terventions for the older patient population with multimorbidity,
without solely focusing on a shared decision-making approach.
We will also evaluate studies of interventions designed to facilitate
patient involvement in decision-making that were not designed
for, but were investigated with our population of interest.
Patients’ perceptions of involvement in decision-making about
their health care are considered important in predicting outcomes
(Saba 2006). For example, there are positive associations between
patients’ trust in a general practitioner (GP) and their perceptions
of having been involved in decision-making. The strength of this
association increases with patient age (Croker 2013). A brief re-
view of the current literature suggests it is difficult to draw firm
conclusions regarding which types of interventions might most
effectively facilitate the adoption of patient involvement in deci-
sion-making by primary care practitioners (Légaré 2018).
A 2007 Cochrane Review considered interventions to improve
older patients’ involvement in primary care consultations, includ-
ing their involvement in decision-making about their health care
(Wetzels 2007); however it did not address the issue of multimor-
bidity. At that time, the review authors reported on three relevant
intervention studies, and concluded that the available evidence
was sparse. However, that review is now dated, and we believe that
new research is available. A systematic review of this evidence will
provide greater clarity regarding the best use of interventions to
support the involvement of older patients with multimorbidity
in decision-making about their care, in order to achieve positive
outcomes for patients, doctors, and healthcare teams as outlined
above.
Why it is important to do this review
There are concerns that current delivery of good quality care is not
meeting the needs of older patients who often experience multi-
morbidity (Salisbury 2012; Steel 2014). Older patients account
for a large percentage of spending in primary care; 37% in the
UK (RCGP 2013). Such patients consult more frequently (Hobbs
2016), creating a substantial component of the primary care work-
load. The burden on primary care from this vulnerable patient
group can be expected to increase as the prevalence of multimor-
bidity in the older age groups is predicted to rise (from 45.7% in
2015, to 52.8% in 2035 for people aged 65 to 74 years) (Kingston
2018). It is only recently that the needs and benefits to older pa-
tients with multimorbidity of participating in decision-making
about their health care have been acknowledged.
The National Institute for Clinical Excellence (NICE) in the UK
has recently published guidelines for the clinical assessment and
management of patients with multimorbidity (NICE 2016). The
guidelines recommend that patients with multimorbidity should
be involved in decision-making about their health care. However,
the authors provide little instruction on how to achieve this. Our
review is warranted to provide evidence-based guidance to policy
makers, researchers, and commissioners about how to direct fund-
ing towards good quality interventions targeting the involvement
of older patients in decision-making about their health care, and
to provide practical guidance to clinicians when adopting these
interventions.
We acknowledge six reviews, identified by a brief literature search
and by seeking the advice of content experts, and we discuss
the similarities and differences between these reviews and our
proposed review by using the Donabedian structure/process/out-
comes model (McDonald 2007). We discuss why our proposed
review is needed to fill an important gap in the current literature
(see Table 1).
There are other reviews of shared decision-making interventions.
However, we feel it is important to carry out a review of all inter-
ventions developed with the aim of facilitating the involvement of
patients with multimorbidity in decision-making about their care,
specifically older patients with multimorbidity. Therefore our re-
view will have a wider scope than those specifically focused on the
evaluation of shared decision-making tools and instruments.
We are not aware of any significant overlap with other Cochrane
or non-Cochrane Reviews, either published or in progress.
Our review will inform the development of a new intervention to
facilitate the involvement of older patients with multimorbidity in
decision-making about their health care when visiting a primary
care physician. Feasibility testing will then inform the planning
and design of a future definitive randomised controlled trial of the
intervention. We hope that other researchers will use this review to
similarly inform their work to support this growing and vulnerable
patient population.
O B J E C T I V E S
To explore the effectiveness of interventions delivered with the
aim of involving older patients with multimorbidity in decision-
making about their health care during primary care consultations.
M E T H O D S
Criteria for considering studies for this review
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Types of studies
We will include randomised controlled trials (RCTs), cluster-
RCTs, and quasi-RCTs (a trial in which randomisation is at-
tempted but subject to potential manipulation, such as allocating
participants by day of the week, date of birth, or sequence of entry
into a trial). We anticipate that few properly RCTs will have been
conducted on the subject asmany studies specifically exclude older
patients or those with more than one health problem.
Types of participants
The patient participant population will be older patients (aged
65 years and over) with multimorbidity (more than one long-
term health problem), and will include their carers. However, we
anticipate that searching for studies with such specific participant
inclusion criteria may limit our findings, therefore we will include
studies of multimorbidity where we can differentiate the study
findings by patient age, or obtain this information from the study
authors, with stratification where possible. We will also include
studies if 75% or more of the patient population are aged 65 years
or over.
We, like most researchers conducting studies in developed world
countries, have accepted the chronological age of 65 years and
above as a definition of an older person. However we recognise
that, like many westernised concepts, this does not adapt well to
the situation in developing countries.
We will include any study where the study authors’ definition of
multimorbidity is encompassed by our own. Our definition of
‘more than one long-term health problem’ therefore encompasses
studies where multimorbidity is defined as ‘three or more chronic
conditions’, for example.
Wewill not specify aminimum length of time for long-term condi-
tions, examples of which include: angina or heart problem; arthri-
tis or joint problem; asthma or chest problem; blindness or severe
visual impairment; cancer in the last five years; deafness or severe
hearing impairment; diabetes; epilepsy; high blood pressure; kid-
ney or liver disease; back problem; mental health problem; and
neurological problem. We adapted this list from the English Na-
tional General Practice Patient Survey. Where dyads of conditions
occur within the same category, e.g. anxiety and depression, we
will only count these as one condition e.g. mental health problem.
We define primary care as “first-contact, continuous, comprehen-
sive, and coordinated care provided to populations undifferenti-
ated by gender, disease, or organ system” (Starfield 1994). We will
include all interventions involving patients, their carers, primary
care practitioners, and primary care administration staff (includ-
ing receptionists) that are delivered within primary care with the
aim of improving patient involvement within a primary care con-
sultation. This will include interventions delivered in the patient’s
home but initiated by the primary healthcare team. We will in-
clude patients in care or nursing homes. We will include carer
participation because this is likely to be of relevance to consulta-
tions involving vulnerable older patients with multimorbidity. We
recognise that interventions may have multiple components that
will be important to capture, and that using administration staff,
to ensure organisational change within the practice, may be one
of these elements. We will not exclude patient participants based
on whether they have public or private insurance.
We will include studies involving interventions delivered by all
types of practitioner working within primary care, e.g. doctors,
nurses, physiotherapists, occupational therapists, mental health
workers, and pharmacists. We will exclude dentists because the fo-
cus will be around general medical practice. We will include inter-
ventions delivered by non-clinical researchers or teachers/trainers
to patients or practitioners, for example, training in communica-
tion skills.
Interventions may be directed at patients, primary care practition-
ers, or both. Interventions may also be delivered to patients by pri-
mary care practitioners, and in some situations practitioners may
receive one element of an intervention (e.g. training in commu-
nication skills) and deliver another element (e.g. written support
tool used during a consultation).
Alternatively, or additionally, interventions may involve organisa-
tional change, for example longer consultation times, within the
practice.
We will exclude interventions delivered by secondary care prac-
titioners to their patients because we consider the primary care
setting to include healthcare practitioners and administrative staff
working within the patient’s general practice surgery, in the wider
community, for example community pharmacies and community
support groups, and in the patient’s home. We will exclude con-
sultations in acute care settings (e.g. accident and emergency de-
partment settings and out of hours services) because we are in-
terested in first-contact, continuous, comprehensive, and co-ordi-
nated care with a primary care practitioner as described by Starfield
1994. We will exclude studies where only part of the intervention
was delivered or facilitated via primary care, unless it is possible to
differentiate findings according to intervention setting.
Types of interventions
There may be different types of interventions with the common
aim of involving patients in decision-making about their health
care. We expect to find face-to-face interventions for patients and/
or practitioners, written or online information sheets and prompts
for use before or during consultations, and some elements of or-
ganisational change within the primary care environment.
As we are interested in all interventions that facilitate patient in-
volvement in decision-making about their health care, this is not
limited to a shared decision-making approach. Therefore, we will
not specify that the intervention meets a certain number of shared
decision-making elements (Elwyn 2000). Equally, whilst we recog-
nise that shared decision-making usually requires shared equipoise
informed by the preferences and values of the patient and prac-
4Interventions for involving older patients with multimorbidity in decision-making during primary care consultations (Protocol)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
titioner, we will not exclude interventions whereby the goal has
already been set by the heath practitioner, e.g. motivational inter-
viewing approaches, or by the patient.
We will include interventions if they only address a decision-mak-
ing process surrounding a single long-term condition in a patient
with multimorbidity, as long as the aims of the study are to facili-
tate patient involvement in decision-making about their care.
We will include both patient-focused and practitioner-focused
interventions taking place either before or during consultations.
These may relate to single patient encounters with a practitioner
or may relate more broadly to patients’ use of primary health care.
Interventions may focus on the use of healthcare information re-
sources, on preparing patients for patient-practitioner contacts, or
on training practitioners in consultation skills.
Patient-focused interventions might include patient decision-aids:
mailouts pre-consultation, advising patients how to actively seek
involvement in decision-making about their care during a consul-
tation; ‘option grids’ and ‘risk diagrams’ delivered by practitioners
to aid involvement in decision-making regarding medications or
regarding investigations during consultations; handheld patient
care plans with documentation of shared decisions made between
patient and practitioner to aid in subsequent follow-up discussions
about these decisions; conversation aids “designed to encourage
and directly support the conversations that patients and clinicians
have when making decisions together” (Montori 2017); and pa-
tient agenda cards (Hamilton 2006).
Practitioner-focused interventions might involve training in pa-
tient-centred communication skills and interventions that raise
practitioner awareness of the potential benefits of involvement in
decision-making for this patient group.
Studies of interventions encompassing organisational change
might include longer consultations for older patients with multi-
morbidity in order to allow time for effective involvement in de-
cision-making, or allowing for a third person, e.g. a carer, to be
present within the consultation to act as a facilitator of the pa-
tient’s involvement. We will include interventions solely focused
on improving appointment availability, waiting lists, and consul-
tation duration only where the intervention is explicitly aiming to
facilitate the involvement of older patients with multimorbidity
in decision-making about their health care.
Interventions delivered by clinician-researchers could include
leaflets for patients or training for practitioners. Interventions de-
livered by practitioners to patients during consultations could be
based on the use of patient-centred communication skills. Inter-
ventions delivered by administration staff to patients could include
mailouts of information sheets and decision-aids, or distribution
of consultation prompts in the waiting room.
We will include studies that compare the intervention with usual
care or with no intervention. We will include studies with multi-
ple arms, evaluating the effectiveness of one form of intervention
versus another, or evaluating the effectiveness of more than one
intervention by comparing each with usual care.
Wewill exclude studies where decision-making about hypothetical
issues has taken place.
We will include studies where interventions have been investigated
with older patients with multimorbidity, even if the intervention
was not originally designed for this patient population.
We expect to identify studies assessing outcomes frompatient and/
or practitioner and/or observer perspectives.
We will use the TIDieR checklist (Hoffmann 2014), to describe
the intervention components.
Types of outcome measures
The outcomes likely to be main outcomes for the ‘Summary of
findings’ table are: evidence of patient involvement in decision-
making; physical health status; psychological and psychosocial
health status; patient evaluation of care; practitioners’ knowledge
and skills; resource use and cost; and adverse outcomes (patient,
practitioner, or observer perceptions of less patient involvement
in decision-making than prior to the intervention).
We will use the Institute for Healthcare Improvement Triple Aim
(improving the patient experience of care, improving the health
of populations, and reducing the per capita cost of health care) to
guide our selection of secondary outcomes (Berwick 2008).
Primary outcomes
Evidence of patient involvement in decision-making during
the consultation from patient and/or practitioner and/or
observer perspectives
Elwyn 2000 proposed that a sequence of skills should be demon-
strated by the practitioner in order to involve the patient in the
decision-making process. These skills can be measured by a vari-
ety of scales, including by an observer using the OPTION scale
(Elwyn 2005):
• implicit or explicit involvement of patients in the decision-
making process;
• explore ideas, fears, and expectations of the problem and
possible treatments;
• portrayal of equipoise and options;
• identify preferred data format and provide tailor-made
information;
• checking process: understanding of information and
reactions (e.g. ideas, fears, and expectations of possible options);
• acceptance of process and decision making role preference;
• make, discuss, or defer decisions; and
• arrange follow-up.
Simple rating scales, such as those used in the General Practice
Patient Survey in England (Croker 2013), can be used to measure
patient and practitioner perceptions, including whether patient
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involvement in decision-making about their health care took place
during a primary care consultation.
Secondary outcomes
Patient and carer outcomes
• Physical health status: clinical outcomes (physiological
measures), other patient-reported physical health outcomes
(from patient-reported outcome measures and the Charlson
index of comorbidity (Charlson 1987);.
• psychological and psychosocial health status: including
patient quality of life, social behaviour, life satisfaction (from
short-form health surveys such as the World Health
Organization (WHO) quality of life instrument (WHO 2012));
• treatment burden: medication burden (polypharmacy, co-
ordinating medication, obtaining prescriptions, using devices),
prescribed lifestyle changes (diet, exercise, smoking, alcohol),
self-monitoring, impact on relationships (family/friends/carers);
• health behaviours: adherence to treatment plans (from
practice databases and patient survey data), patient-initiated
lifestyle changes (diet, exercise, smoking, alcohol);
• knowledge and skills acquisition for patients: information
access; knowledge about diseases/conditions; knowledge about
treatments and risks, health beliefs; patient enablement for self-
care (Howie 1998); symptom control skills; health enhancing
lifestyle measures;
• patient evaluation of care: patient satisfaction with
practitioners and care procedures; trust in the practitioner;
perceptions of practitioner behaviours (knowledge, skills,
empathy, attitudes regarding patient involvement); complaints.
Tools could include the Patient Perceptions of Patient-
Centredness (PPPC) instrument (Stewart 2000), and the
General Practice Patient Survey (Croker 2013);
• carer support: patient perceptions or ratings of carer
support;
• carer evaluation of care: ratings of satisfaction with the
encounter.
Practitioner outcomes
• Knowledge and skills: knowledge of the potential benefits
of patient involvement in the decision-making process;
competence in patient-centred communication skills e.g. shared
decision-making skills (as assessed by the OPTION scale Elwyn
2005 or similar);
• attitudes (towards the intervention and compliance with it);
• practitioner satisfaction with the intervention.
Health service outcomes
• Resource use and cost: length of consultation, frequency of
attendance, types of appointment, cost implications of rates of
referral and investigation, accident and emergency department
attendance, hospital admissions;
• organisational change as a result of evaluation of the
intervention: patient feedback (satisfaction with care
procedures); practice administrative evaluation (feasibility of
intervention); economic evaluation.
Adverse outcomes
• Patient, practitioner, or observer perceptions of less patient
involvement in decision-making than prior to the intervention;
adverse effects of medications; inappropriate frequency of
appointment attendance (in excess or did not attend);
unwarranted treatments/procedures; increase in hospital
admissions and accident and emergency department attendances;
increased anxiety in patient due to the intervention process;
stress of the patient due to receiving information; increased
practitioner anxiety/stress from the intervention; complaints.
At the protocol stage wemay not be able to predict every secondary
outcome reported by included studies. However, we have selected
a primary outcome, a main adverse outcome, and pre-specified
secondary outcome categories for use at the review stage. We will
apply the categorisation process to meta-analysis or narrative syn-
thesis of outcomes and to the selection of outcomes for reporting
in the ‘Summary of findings’ table.
Two review authors will independently assign the outcomes re-
ported in each included study to the review’s outcome categories
and will resolve any differences in categorisation, if they occur, by
involving a third review author. This may mean that we assign
more than one outcome to each outcome category per study at
review stage. In this scenario, we will:
• select the primary outcome identified by the publication
authors;
• where no primary outcome has been identified, select the
one specified in the sample size calculation;
• if there are no sample size calculations, rank the effect
estimates (i.e. list them in order from largest to smallest) and
select the median effect estimate. Where there is an even number
of outcomes the outcome whose effect estimate is ranked n/2,
where n is the number of outcomes, can be selected;
• if this approach is not feasible, we will list the outcomes for
each trial (without considering either the size of the effect or its
statistical significance) and will decide which is most ‘clinically’
important. Two review authors will independently decide before
mutual discussion of the decision and will consult a third review
author if disagreements occur.
It will not be appropriate to define, in advance, the timing of
outcome assessment.
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Search methods for identification of studies
Electronic searches
We will search the following electronic databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL, the Cochrane Library, latest issue);
• MEDLINE (OvidSP) (1966 to present);
• Embase (OvidSP) (1988 to present);
• PsycINFO (OvidSP) (1806 to present);
• CINAHL (Ovid) (1982 to September 2008) then in Ebsco
when no longer indexed by Ovid (2009 to present);
• Centre for Reviews and Dissemination Databases (Database
of Abstracts and Reviews of Effects (DARE));
• Health Technology Assessment (HTA) Database;
• Ongoing Reviews Database; and
• Dissertation Abstracts International (1861 to present).
The MEDLINE (OvidSP) search strategy is in Appendix 1.
We will tailor strategies to other databases and report them in the
review. There will be no language or date restrictions.
Searching other resources
We will seek additional studies by searching the reference lists of
relevant trials and reviews identified. In addition, we will examine
our personal literature collections to identify relevant studies. We
will contact experts in the field and authors of included studies for
advice as to other relevant studies. We will also search online trial
registers (WHO International Clinical Trials Registry Platform,
National Institutes of Health, ClinicalTrials.gov) for ongoing and
recently completed studies.
As an intervention review, we will run the resulting Endnote Li-
brary of all references through the Cochrane RCT Classifier.
We will also consider searching sources of grey literature.
Data collection and analysis
Selection of studies
Two review authors will independently screen all titles and ab-
stracts identified from searches to determine which meet the in-
clusion criteria. We will retrieve the full-text articles identified as
potentially relevant by at least one review author. Two review au-
thors will independently screen full-text articles for inclusion or
exclusion, and will resolve discrepancies by discussion and by con-
sulting a third review author if necessary to reach consensus. We
will list all potentially relevant papers excluded from the review at
this stage as excluded studies, with reasons provided in the ‘Char-
acteristics of excluded studies’ table. We will also provide citation
details and any available information about ongoing studies, and
collate and report details of duplicate publications, so that each
study (rather than each report) is the unit of interest in the review.
We will report the screening and selection process in an adapted
PRISMA flow chart (Liberati 2009).
Data extraction and management
Two review authors will extract data independently from included
studies. Any discrepancies will be resolved by discussion until con-
sensus is reached, or through consultation with a third review au-
thor where necessary. We will develop and pilot a data extraction
form using the Cochrane Consumers and Communication data
extraction template.
We will extract data on: study details (aim of intervention, study
design including type of intervention (practitioner/patient-fo-
cused), description of comparison group, recruitment and reten-
tion, randomisation, blinding), description of participants (coun-
try, setting, age, gender, ethnicity, socio-economic status, frailty,
mobility, receipt of carer support andwhether the carer was present
during the consultation, communication vulnerability (e.g. health
literacy, sensory impairment, cognitive impairment, local language
proficiency), exclusions), definition of multimorbidity used in the
study (whether numbers of long-term health problems were listed
and counted, and the types and numbers recorded), types of inter-
vention (written support tools versus communication skills train-
ing; timing of intervention delivery, either before or during a con-
sultation; whether the intervention was a single episode of care
versus multiple episodes), outcomes (timing of outcome assess-
ment, primary and secondary outcomes). We will use the TIDieR
checklist (Hoffmann 2014), to describe the intervention compo-
nents.
Assessment of risk of bias in included studies
We will assess and report on the methodological risk of bias of
included studies in accordance with theCochrane Handbook of Sys-
tematic Reviews of Interventions (Higgins 2011), and the Cochrane
Consumers and Communication guidelines (Ryan 2013), which
recommends the explicit reporting of the following individual
elements for RCTs: random sequence generation; allocation se-
quence concealment; blinding (participants, personnel); blinding
(outcome assessment); completeness of outcome data; and selec-
tive outcome reporting. We will consider blinding separately for
different outcomes where appropriate (for example, blinding may
have the potential to differently affect subjective versus objective
outcome measures). We will judge each item as being at high, low,
or unclear risk of bias as set out in the criteria provided by Higgins
2011, and provide a quote from the study report and a justification
for our judgement for each item in the ’Risk of bias’ table.
We will deems studies to be at the highest risk of bias if they are
scored as at high or unclear risk of bias for either the sequence
generation or allocation concealment domains, based on growing
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empirical evidence that these factors are particularly important
potential sources of bias (Higgins 2011). We will assess and report
quasi-RCTs as being at a high risk of bias on the random sequence
generation item of the ’Risk of bias’ tool. For cluster-RCTs we will
also assess and report the risk of bias associated with an additional
domain: selective recruitment of cluster participants. Two review
authors will assess studies to identify if an alternative design, using
individual randomisation, could have been employed. We will
extract data on the randomisation procedure and the likelihood
of this introducing bias to the selection of participants into the
study.
In all cases, two review authors will independently assess the risk
of bias of included studies, and will resolve any disagreements by
discussion to reach consensus. We will contact study authors for
additional information about the included studies, or for clarifi-
cation of the study methods as required. We will incorporate the
results of the ’Risk of bias’ assessment into the review through stan-
dard tables, and systematic narrative description and commentary
about each of the elements, leading to an overall assessment the
risk of bias of included studies and a judgment about the internal
validity of the review’s results.
We will not restrict our meta-analysis to only low risk of bias
studies but will instead explore the effects of risk of bias through
sensitivity analysis.
Measures of treatment effect
For dichotomous outcomes, we will analyse data based on the
number of events and the number of people assessed in the inter-
vention and comparison groups. We will use these to calculate the
risk ratio (RR) and 95% confidence interval (CI). For continuous
measures, we will analyse data based on the mean, standard devi-
ation (SD), and number of people assessed for both the interven-
tion and comparison groups to calculate mean difference (MD)
and 95%CI. If theMD is reported without individual group data,
we will use this to report the study results. If more than one study
measures the same outcome using different tools, we will calculate
the standardised mean difference (SMD) and 95% CI using the
inverse variance method in Review Manager 5 (Review Manager
2014).
Unit of analysis issues
If cluster-RCTs meet the inclusion criteria, we will check for unit-
of-analysis errors. If we identify errors and sufficient information is
available, we will re-analyse the data using the appropriate unit of
analysis by taking account of the intra-cluster correlation (ICC).
We will obtain estimates of the ICC by imputing them using esti-
mates from external sources. If we are unable to obtain sufficient
information to re-analyse the data, we will report effect estimates
and annotate unit-of-analysis error.
Dealing with missing data
We will attempt to contact study authors to obtain missing data
(participant, outcome, or summary data). For participant data,
we will, where possible, conduct analysis on an intention-to-treat
basis; otherwise we will analyse data as reported.We will report on
the levels of loss to follow-up and assess this as a source of potential
bias.
Formissing outcome or summary datawewill imputemissing data
where possible and report any assumptions in the review. We will
investigate, through sensitivity analyses, the effects of any imputed
data on pooled effect estimates.
Assessment of heterogeneity
Where we consider studies similar enough (based on consideration
of populations or interventions) to allow pooling of data using
meta-analysis, we will assess the degree of heterogeneity by visual
inspection of forest plots and by examining the Chi² test for het-
erogeneity. Heterogeneity will be quantified using the I² statistic.
We will consider an I² statistic value of 50% or more to represent
substantial levels of heterogeneity, but we will interpret this value
in light of the size and direction of effects and the strength of the
evidence for heterogeneity, based on the P value from the Chi²
test (Higgins 2011).
Where we detect substantial clinical, methodological, or statistical
heterogeneity across included studies, we will not report pooled
results frommeta-analysis but will instead use a narrative approach
to data synthesis. In this event, we will attempt to explore possible
clinical or methodological reasons for this variation by grouping
studies that are similar in terms of populations, intervention fea-
tures, or methodological features to explore differences in inter-
vention effects.
Assessment of reporting biases
We will assess reporting bias based on the characteristics of the
included studies. If only small studies indicating positive findings
are identified for inclusion, we will use qualitative methods to re-
port bias. Similarly, we will report bias qualitatively if information
that we obtain from contacting experts and study authors suggests
that there are unpublished studies of relevance to the review.
If we identify sufficient studies (at least 10) for inclusion in the
review we will construct a funnel plot to investigate small study
effects, which may indicate the presence of publication bias. We
will formally test for funnel plot asymmetry, with the choice of
test made based on advice in Higgins 2011, and bearing in mind
that there may be several reasons for funnel plot asymmetry when
interpreting the results.
Data synthesis
We will decide whether to meta-analyse data based on whether
the interventions in the included trials are similar enough in terms
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of participants, settings, intervention, comparison, and outcome
measures to ensure meaningful conclusions from a statistically
pooled result. Due to the anticipated variability in the populations
and interventions of included studies, we will use a random-effects
model for meta-analysis.
If we are unable to pool the data statistically using meta-analysis
we will conduct a narrative synthesis of results. We will present the
major outcomes and results, organised by intervention categories
according to the major types and/or aims of the identified inter-
ventions. Depending on the assembled research, we may also ex-
plore the possibility of organising the data by population. Within
the data categories we will explore the main comparisons of the
review:
• intervention versus control (no intervention, wait list,
placebo);
• intervention versus usual care;
• one form of intervention versus another.
Where studies compare more than one intervention, we will com-
pare each separately to no intervention/control.
If we are unable to pool the data statistically using meta-analysis,
we will group the data based on the category that best explores the
heterogeneity of studies andmakes most sense to the reader (i.e. by
interventions, populations, or outcomes). Within each category
we will present the data in tables and narratively summarise the
results. We will consider the Foundations Framework for Devel-
oping and Reporting New Models of Care for Multimorbidity,
Stokes 2017, when we report our findings.
Subgroup analysis and investigation of heterogeneity
The potential subgroups for analysis will include: the type of in-
tervention e.g. written support tools versus communication skills
training; timing of intervention delivery, either before or during a
consultation; whether the intervention was a single episode of care
versus multiple episodes (and whether these were with the same
practitioner). Subgroup analyses investigating intervention type
and delivery will be important for practitioners and policy makers
looking to implement these types of interventions into practice,
in order to inform them regarding the most effective approach.
To reduce the chance of observing spurious results by undertaking
too many subgroup analyses, we have limited the number to those
of most relevance to this review.
It may not be possible to pool data statistically to carry out sub-
group analysis or there may be too few included studies to war-
rant statistical subgroup analyses, by intervention components for
instance. Therefore we will present a narrative form of subgroup
analyses where it is not possible to do so statistically.
Sensitivity analysis
We will use sensitivity analysis to assess the robustness of results,
such as the impact of notable assumptions, imputed data, choice
of meta-analysis method, and inclusion of studies at high risk of
bias. We plan to base the sensitivity analysis on the ’Risk of bias’
assessment, comparing the results of studies at higher and lower
risk of bias. We will remove lower quality studies from the analysis
and see how robust the results are when based only on higher
quality studies.
We will consider formally comparing ’Risk of bias’ assessments
using meta-regression; however, a minimum of 10 studies is rec-
ommended for meta-regression for each variable included in the
model (Thompson 2002). This may not be feasible if only a small
number of studies meet the inclusion criteria of the review.
Not all decisions regarding sensitivity analyses will be possible be-
fore the review is conducted; we will need to make some decisions
based on the assembled data and included studies. To minimise
bias we will identify the relevant sensitivity analyses a priori, i.e.
once we have ascertained the scope of the data set, but before we
undertake statistical analysis.
’Summary of findings’ table
Wewill prepare a ’Summary of findings’ table to present the results
of meta-analysis, based on the methods described in Chapter 11
of the Cochrane Handbook for Systematic Reviews of Interventions
(Schünemann 2011). We will present the results of meta-analy-
sis for the major comparisons of the review, including the major
primary outcome, as outlined in the ’Types of outcome measures’
section. We will provide a source and rationale for each assumed
risk cited in the table(s), and will use the GRADE system to as-
sess the quality of the evidence using GRADEpro GDT software
(GRADEpro GDT 2015; Schünemann 2011). If meta-analysis is
not possible, we will present results in a narrative ’Summary of
findings’ table format, such as used by Chan 2011.
Ensuring relevance to decisions in health care
At least one consumer peer reviewer and one health professional
peer reviewer will provide feedback on the protocol and the review
as part of Cochrane’s standard editorial processes.
Using links with the patient involvement group from theNational
Institute for Health Research (NIHR) Collaboration for Leader-
ship in Applied Health Research and Care, South West Penin-
sula (PenCLAHRC), we have established a group of eight older
members of the public who have varying degrees of morbidity and
varying health service experiences. We will arrange workshops to
enable these Patient and Public Involvement group members to
advise on the direction of the review and to ensure end-user rele-
vance of the presentation of our results.
The lead author is a GP and therefore has insight into the rele-
vance of our review to primary health care. In addition, we will
seek the opinions of content experts, including primary healthcare
practitioners with a special interest in older patients and experts on
shared decision-making, regarding relevant evidence and theory,
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and ask for critical appraisal of our review methods and results.
We will discuss methods of delivering our results that are accept-
able, engaging, and sustainable in context, giving consideration to
resource allocation, recruitment issues, and the format of future
evaluation.
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A D D I T I O N A L T A B L E S
Table 1. A comparison of our proposed review with existing systematic reviews of similar interventions
Systematic review Structure Processes Outcomes
Interventions for improving
outcomes in patients with mul-
timorbidity in primary care and
community settings. Smith
2016
Smith 2016 excluded interven-
tions that included people with
comorbid conditions where the
intervention was targeted solely
at one condition. We will in-
clude studies where older peo-
ple with multimorbidity were
exposed to an intervention to
facilitate patient involvement in
their healthcare, and where out-
comes were reported in respect
of this population, even if the
intervention was not originally
designed for older patients with
multimorbidity
Smith 2016 did not design their
search strategy to find studies
of interventions to facilitate the
involvement of older patients
with multimorbidity in deci-
sion-making about their care,
which is the aim of our review
Smith 2016 was not specif-
ically interested in the pro-
cesses within, and supporting,
a general practice consultation,
which is the focus of our review
Our review will differ from
Smith 2016 as our primary out-
come, of whether or not pa-
tient involvement in the deci-
sion-making process occurred
during a consultation, was not a
primary outcome, or a specific
focus of a secondary outcome,
in Smith 2016.
Smith 2016 excluded the out-
comes of attitude and knowl-
edge when reporting studies,
both of which are highly rele-
vant to the delivery of patient-
centred care, and to patient
involvement in decision-mak-
ing about their healthcare dur-
ing a primary care consultation.
Our review will include these
outcomes in order to inform
clinicians and policy makers
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Table 1. A comparison of our proposed review with existing systematic reviews of similar interventions (Continued)
about interventions support-
ing improved patient knowl-
edge of their conditions and
treatments, improved patient
enablement for self-care, posi-
tive changes in patients’ health
beliefs and lifestyle choices, pa-
tient satisfaction with health-
care and trust in the practi-
tioner, and improved practi-
tioner communication skills in-
cluding shared-decision mak-
ing. Attitudes towards the in-
tervention and compliancewith
it will also be important in
the development of future in-
terventions to facilitate the in-
volvement of older patients
with multimorbidity in deci-
sion-making about their health-
care
Interventions for providers to
promote a patient-centred ap-
proach in clinical consultations.
Dawmena 2012
Dawmena 2012 included stud-
ies of interventions facilitat-
ing shared decision-making,
however they focus only on
studies of interventions di-
rected at healthcare profession-
als, or at healthcare profession-
als and patients together. Our
review would additionally in-
clude studies of interventions
targeting only patients, and in
particular the very important
and vulnerable patient popula-
tion of older patients with mul-
timorbidity
- -
Personalised care planning for
adults with chronic or long-
termhealth conditions. Coulter
2015
The type of care planning eval-
uated by Coulter 2015 does
not routinely take place within
a primary care consultation
alone, being more likely to be
initiated by a secondary care
specialist liasing with the pri-
mary care team. Primary care
will be the focus of our review
Coulter 2015 looked at per-
sonalised care planning and
their inclusion criteria captures
a subset of studies evaluating el-
ements of patient involvement
in decision-making.Our review
criteria are much broader in
terms of studies to facilitate pa-
tient involvement
-
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Table 1. A comparison of our proposed review with existing systematic reviews of similar interventions (Continued)
Interventions before consulta-
tions for helping patients ad-
dress their information needs.
Kinnersley 2008
Kinnersley 2008 focused on in-
terventions targeted only at pa-
tients, whereas we are interested
in interventions aimed at pa-
tients, practitioners, or both, as
well as any elements of organi-
sational change
Kinnersley 2008 looked at stud-
ies of interventions to support
patients in information gather-
ing from a doctor or a nurse
during a consultation. Whilst
this is an important aspect of
patient involvement, it is only
one element of a complex pro-
cess. We therefore feel that the
inclusion criteria used in this
review will have missed many
studies that are of relevance to
our review
-
Interventions for improving the
adoption of shared decision
making by healthcare profes-
sionals. Légaré 2018
This review covers an impor-
tant topic in the research area of
shared decision-making. How-
ever, it focuses only on stud-
ies of interventions designed
to improve the healthcare pro-
fessional’s adoption of shared
decision-making and excludes




Interventions for improving pa-
tients’ trust in doctors and
groups of doctors. Rolfe 2014
- We know from our own work
that there are associations be-
tween patients’ trust in the doc-
tor and their involvement in de-
cision-making about their care.
Studies of interventions to pro-
mote patient involvement in
decision-making would be in-
cluded by Rolfe 2014. How-
ever the scope of this review is
very broad and it does not ad-
dress our aim; to systematically
review studies of interventions
that facilitate patient involve-
ment, focusing on older people
with multimorbidity
-
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. exp aged/
2. Aging/
3. (Late life or elder* or aged or old age or geriatric or seniors).ti,ab,kw.
4. ((old or older or aging or aged or senior or elder*) adj3 (person or persons or people or adult* or subject* or patient* or consumer*




8. exp Decision Making/
9. Decision Support Techniques/













23. exp Community Participation/
24. Stakeholder Participation/
25. exp Patient-Centered Care/
26. ((patient* or consumer* or user* or carer* or caregiver* or client* or famil* or lay*) adj3 (partner* or participat* or centre* or
center* or communicat* or consult* or decision* or deliberation* or co#design* or involv* or contribut* or role* or empower* or





30. (multidisease* or multi-disease* or multimorbidit* or comorbid* or multi-morbidit* or co-morbid*).ti,ab,kw.
31. ((concomit* or concurren* ormulti* ormultiple) adj3 (ill* or condition* ormorbidit* or syndrom* or disorder* or disease*)).ti,ab,kw.
32. exp Chronic Disease/
33. (chronic* adj3 (disease* or ill* or care or condition? or disorder* or health* or medication* or syndrom* or symptom* or
chronic*)).ti,ab,kw.
34. ((coocur$ or co-ocur$ or coexist$ or co-exist$ or multipl$) adj3 (disease? or ill$ or care or condition? or disorder$ or health$ or
medication$ or symptom$ or syndrom$)).ti,ab,kw.
35. or/28-34
36. exp Primary Health Care/
37. General Practice/
38. General Practitioners/
39. exp Home Care Services/
40. physicians, family/
41. Physicians, primary care/
42. Private Practice/
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43. “Family Practice”/
44. Community Health Services/
45. Community Health Nursing/
46. Community Pharmacy Services/
47. Community Health Workers/
48. Preventive Health Services/
49. Primary care nursing/
50. Community medicine/
51. Community health centres/
52. Health Promotion/
53. health promotion.ti,ab,kw.
54. ((home* or visit* or preventive* or general or family or primary or community) adj3 (health or practice* or medicine or physician*
or nursing or pharmacy or program* or service* or care)).ti,ab,kw.
55. ((family or primary or general or community) adj2 (pharmacist* or physician* or doctor* or practitioner* or healthcare*)).ti,ab,kw.
56. ((nurse* or nursing) adj2 (practice* or practitioner* or prescriber*)).ti,ab,kw.
57. (GPs or GPSI or GPwSI).ti,ab,kw.
58. or/36-54
59. randomized controlled trial.pt.








68. quasi experimental study/
69. pragmatic clinical trial/
70. or/67-69
71. (animals not (humans and animals)).sh.
72. 70 not 71
73. and/5,27,35,58,72
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